Market
why Regulus Therapeutics Inc [RGLS] is a Good Choice for Investors After New Price Target of $7.67
Regulus Therapeutics Inc [NASDAQ: RGLS] price surged by 71.01 percent to reach at $0.98. The company report on March 12, 2024 at 6:32 AM that Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity. Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on
